The ability of HDL to inhibit inflammation in adipocytes and adipose tissue is reduced when HDL contains serum amyloid A (SAA) that is trapped by proteoglycans at the adipocyte surface. Because we recently found that the major extracellular matrix proteoglycan produced by hypertrophic adipocytes is versican, whereas activated adipose tissue macrophages produce mainly biglycan, we further investigated the role of proteoglycans in determining the antiinflammatory properties of HDL. The distributions of versican, biglycan, apolipoprotein A1 (the major apolipoprotein of HDL), and SAA were similar in adipose tissue from obese mice and obese human subjects. Colocalization of SAA-enriched HDL with versican and biglycan at the cell surface of adipocyte and peritoneal macrophages, respectively, was blocked by silencing these proteoglycans, which also restored the antiinflammatory property of SAA-enriched HDL despite the presence of SAA. Similar to adipocytes, normal HDL exerted its antiinflammatory function in macrophages by reducing lipid rafts, reactive oxygen species generation, and translocation of Toll-like receptor 4 and NADPH oxidase 2 into lipid rafts, effects that were not observed with SAA-enriched HDL. These findings imply that SAA present in HDL can be trapped by adipocyte-derived versican and macrophage-derived biglycan, thereby blunting HDL’s antiinflammatory properties.
27 October 2026 in Journal of Trauma and Acute Care Surgery
BACKGROUND: Severe trauma induces a cytokine storm that is associated with impaired resuscitation and recovery. We investigated the impact of AQB-565, an anti-inflammatory melanocortin fusion polypeptide, as a novel treatment adjunct for whole blood resuscitation of hemorrhagic shock using a rat polytrauma shock model. METHODS: Hemorrhagic shock with polytrauma was induced in 64 Sprague-Dawley rats. The rats were randomized to receive one of four intravenous treatments at 15 minutes posthemorrhage (T15): saline control, AQB-565, tranexamic acid (TXA), or combined AQB-565+ TXA. The rats were given autologous transfusion of shed whole blood at 60 minutes and as needed thereafter to achieve mean arterial pressure (MAP) of 60 mm Hg for up to 3 hours. Survival, hemodynamics, cytokine profiles, and hemorrhage volumes were compared between groups. RESULTS: There was a significant overall effect of treatment group on MAP (two-way rmANOVA p =0.02) that coincided with blood transfusion. MAP was significantly increased at T105 with AQB-565+TXA versus saline control ( p =0.046). Inflammatory plasma cytokines, including interleukin-6, were significantly decreased with AQB-565 versus control groups (ANOVA p values ≤ 0.01). Seventeen (26.6%) rats died before 3 hours. There was a trend towards increased survival for treatments containing AQB-565 versus controls that was not statistically significant (Kaplan-Meier log rank p =0.06). CONCLUSIONS: A melanocortin pathway-activating polypeptide suppressed inflammation and improved hemodynamic response to whole blood transfusion in this hemorrhagic shock model.